Cargando…

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate

CONTEXT: Epigallocatechin-3-gallate (EGCG) is unstable and easily oxidized, which limits its applications. Ascorbic acid (Vc) is a natural antioxidant. OBJECTIVE: The effects of EGCG combined with Vc and glycerol on stability and uric acid-lowering activity of EGCG were examined. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Qianjin, Cai, Xiaqiang, Dong, Xu, Wang, Ying, Sun, Minghui, Tai, Lingling, Xu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871600/
https://www.ncbi.nlm.nih.gov/pubmed/33556300
http://dx.doi.org/10.1080/13880209.2021.1878235
_version_ 1784657034226958336
author Xie, Qianjin
Cai, Xiaqiang
Dong, Xu
Wang, Ying
Sun, Minghui
Tai, Lingling
Xu, Yan
author_facet Xie, Qianjin
Cai, Xiaqiang
Dong, Xu
Wang, Ying
Sun, Minghui
Tai, Lingling
Xu, Yan
author_sort Xie, Qianjin
collection PubMed
description CONTEXT: Epigallocatechin-3-gallate (EGCG) is unstable and easily oxidized, which limits its applications. Ascorbic acid (Vc) is a natural antioxidant. OBJECTIVE: The effects of EGCG combined with Vc and glycerol on stability and uric acid-lowering activity of EGCG were examined. MATERIALS AND METHODS: EGCG (aqueous solution), EGCG + Vc (aqueous solution), EGCG (glycerol solution) and EGCG + Vc (glycerol solution) were prepared and incubated under different conditions in vitro. The recovery rate of EGCG was calculated by HPLC. Kunming mice were randomly divided into normal control group, model group, allopurinol (5 mg/kg), EGCG (10 mg/kg), EGCG + Vc (both 10 mg/kg), EGCG (10 mg/kg) + glycerol (60%), and EGCG (10 mg/kg) + Vc (10 mg/kg) + glycerol (60%) (n = 6). Allopurinol was injected intraperitoneally to mice, others were administered intragastrically to (2 cases) mice. All mice were continuously administrated for 7 days, once a day. RESULTS: EGCG recovery rates of EGCG group and EGCG + Vc + glycerol group respectively reached to 32.34 ± 1.86% and 98.90 ± 0.64% when they were incubated for 4 h at 80 °C. EGCG recovery rates reached to 91.82 ± 5.13% (incubated for 6 h at pH 8) and 88.85 ± 2.63% (incubated for 4 h in simulated intestinal fluid) when EGCG incubated with Vc and glycerol. Compared with the model group, UA values of EGCG + Vc + glycerol group reduced by 43.49% while EGCG group reduced by 25.63%. The activities of xanthine oxidase (XOD, 31.41 U/gprot) and adenosine deaminase (ADA, 10.05 U/mgprot), and the mRNA expression levels of glucose transporter 9 (GLUT9, 1.03) and urate transporter 1 (URAT1, 0.44) in EGCG + Vc + glycerol group were notably lower than those of EGCG group (38.12 U/gprot, 13.16 U/mgprot, 1.54, and 0.55). The mRNA expression levels of ATP-binding cassette superfamily G member 2 (ABCG2, 1.39) and organic anion transport 1/2 (OAT1/2, 2.34, 2.53) in EGCG + Vc + glycerol group were notably higher than those of EGCG group (0.57, 1.13, and 1.16). DISCUSSION AND CONCLUSIONS: Our findings suggest that when EGCG used in combination with Vc and glycerol could effectively increase its biology activities and can be generalized to the broader pharmacological studies. This sheds light on the development and application of EGCG in the fields of food and medicine.
format Online
Article
Text
id pubmed-8871600
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88716002022-02-25 Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate Xie, Qianjin Cai, Xiaqiang Dong, Xu Wang, Ying Sun, Minghui Tai, Lingling Xu, Yan Pharm Biol Research Article CONTEXT: Epigallocatechin-3-gallate (EGCG) is unstable and easily oxidized, which limits its applications. Ascorbic acid (Vc) is a natural antioxidant. OBJECTIVE: The effects of EGCG combined with Vc and glycerol on stability and uric acid-lowering activity of EGCG were examined. MATERIALS AND METHODS: EGCG (aqueous solution), EGCG + Vc (aqueous solution), EGCG (glycerol solution) and EGCG + Vc (glycerol solution) were prepared and incubated under different conditions in vitro. The recovery rate of EGCG was calculated by HPLC. Kunming mice were randomly divided into normal control group, model group, allopurinol (5 mg/kg), EGCG (10 mg/kg), EGCG + Vc (both 10 mg/kg), EGCG (10 mg/kg) + glycerol (60%), and EGCG (10 mg/kg) + Vc (10 mg/kg) + glycerol (60%) (n = 6). Allopurinol was injected intraperitoneally to mice, others were administered intragastrically to (2 cases) mice. All mice were continuously administrated for 7 days, once a day. RESULTS: EGCG recovery rates of EGCG group and EGCG + Vc + glycerol group respectively reached to 32.34 ± 1.86% and 98.90 ± 0.64% when they were incubated for 4 h at 80 °C. EGCG recovery rates reached to 91.82 ± 5.13% (incubated for 6 h at pH 8) and 88.85 ± 2.63% (incubated for 4 h in simulated intestinal fluid) when EGCG incubated with Vc and glycerol. Compared with the model group, UA values of EGCG + Vc + glycerol group reduced by 43.49% while EGCG group reduced by 25.63%. The activities of xanthine oxidase (XOD, 31.41 U/gprot) and adenosine deaminase (ADA, 10.05 U/mgprot), and the mRNA expression levels of glucose transporter 9 (GLUT9, 1.03) and urate transporter 1 (URAT1, 0.44) in EGCG + Vc + glycerol group were notably lower than those of EGCG group (38.12 U/gprot, 13.16 U/mgprot, 1.54, and 0.55). The mRNA expression levels of ATP-binding cassette superfamily G member 2 (ABCG2, 1.39) and organic anion transport 1/2 (OAT1/2, 2.34, 2.53) in EGCG + Vc + glycerol group were notably higher than those of EGCG group (0.57, 1.13, and 1.16). DISCUSSION AND CONCLUSIONS: Our findings suggest that when EGCG used in combination with Vc and glycerol could effectively increase its biology activities and can be generalized to the broader pharmacological studies. This sheds light on the development and application of EGCG in the fields of food and medicine. Taylor & Francis 2021-02-08 /pmc/articles/PMC8871600/ /pubmed/33556300 http://dx.doi.org/10.1080/13880209.2021.1878235 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xie, Qianjin
Cai, Xiaqiang
Dong, Xu
Wang, Ying
Sun, Minghui
Tai, Lingling
Xu, Yan
Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
title Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
title_full Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
title_fullStr Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
title_full_unstemmed Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
title_short Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
title_sort effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871600/
https://www.ncbi.nlm.nih.gov/pubmed/33556300
http://dx.doi.org/10.1080/13880209.2021.1878235
work_keys_str_mv AT xieqianjin effectsofepigallocatechin3gallatecombinedwithascorbicacidandglycerolonthestabilityanduricacidloweringactivityofepigallocatechin3gallate
AT caixiaqiang effectsofepigallocatechin3gallatecombinedwithascorbicacidandglycerolonthestabilityanduricacidloweringactivityofepigallocatechin3gallate
AT dongxu effectsofepigallocatechin3gallatecombinedwithascorbicacidandglycerolonthestabilityanduricacidloweringactivityofepigallocatechin3gallate
AT wangying effectsofepigallocatechin3gallatecombinedwithascorbicacidandglycerolonthestabilityanduricacidloweringactivityofepigallocatechin3gallate
AT sunminghui effectsofepigallocatechin3gallatecombinedwithascorbicacidandglycerolonthestabilityanduricacidloweringactivityofepigallocatechin3gallate
AT tailingling effectsofepigallocatechin3gallatecombinedwithascorbicacidandglycerolonthestabilityanduricacidloweringactivityofepigallocatechin3gallate
AT xuyan effectsofepigallocatechin3gallatecombinedwithascorbicacidandglycerolonthestabilityanduricacidloweringactivityofepigallocatechin3gallate